These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9855422)

  • 21. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
    Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ;
    J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endotoxin content in Haemophilus influenzae type b vaccine.
    Ochiai M; Kataoka M; Toyoizumi H; Yamamoto A; Kamachi K; Arakawa Y; Kurata T; Horiuchi Y
    Jpn J Infect Dis; 2004 Apr; 57(2):58-9. PubMed ID: 15118211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine.
    Cheng HK; Rajadurai VS; Amin Z; Sriram B; Yee MF; Han HH; Bock HL; Safary A
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):685-92. PubMed ID: 15689088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR; Granoff DM; Barenkamp SJ; Powers DC; Kennedy D; Irby-Moore S; Homan SM; Mink CM
    J Am Geriatr Soc; 2004 Nov; 52(11):1883-7. PubMed ID: 15507066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolution of conjugate vaccines.
    Mäkelä PH; Käyhty H
    Expert Rev Vaccines; 2002 Oct; 1(3):399-410. PubMed ID: 12901578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.
    Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L;
    Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.
    Chevallier B; Vesikari T; Brzostek J; Knuf M; Bermal N; Aristegui J; Borys D; Cleerbout J; Lommel P; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S109-18. PubMed ID: 19325447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
    Mawas F; Newman G; Burns S; Corbel MJ
    J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children.
    Kim JS; Jang YT; Kim JD; Park TH; Park JM; Kilgore PE; Kennedy WA; Park E; Nyambat B; Kim DR; Hwang PH; Kim SJ; Eun SH; Lee HS; Cho JH; Kim YS; Chang SJ; Huang HF; Clemens JD; Ward JI
    Vaccine; 2004 Sep; 22(29-30):3952-62. PubMed ID: 15364444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines.
    Slack MH; Schapira D; Thwaites RJ; Burrage M; Southern J; Andrews N; Borrow R; Goldblatt D; Miller E
    J Infect Dis; 2001 Dec; 184(12):1617-20. PubMed ID: 11740740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age.
    Halperin SA; Tapiero B; Diaz-Mitoma F; Law BJ; Hoffenbach A; Zappacosta PS; Radley D; McCarson BJ; Martin JC; Brackett LE; Boslego JW; Hesley TM; Bhuyan PK; Silber JL
    Vaccine; 2009 Apr; 27(19):2540-7. PubMed ID: 19124057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
    Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
    Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbohydrate-Based Vaccines: An Overview.
    Hütter J; Lepenies B
    Methods Mol Biol; 2015; 1331():1-10. PubMed ID: 26169731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Conjugated vaccines].
    Fritzell B
    Therapie; 2005; 60(3):249-55. PubMed ID: 16128267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization of newborns with bacterial conjugate vaccines.
    van den Biggelaar AH; Pomat WS
    Vaccine; 2013 May; 31(21):2525-30. PubMed ID: 22728221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjugates and reverse vaccinology to eliminate bacterial meningitis.
    Rappuoli R
    Vaccine; 2001 Mar; 19(17-19):2319-22. PubMed ID: 11257355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycans as Vaccine Antigens and Adjuvants: Immunological Considerations.
    Zimmermann S; Lepenies B
    Methods Mol Biol; 2015; 1331():11-26. PubMed ID: 26169732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycoconjugate vaccines.
    Pace D
    Expert Opin Biol Ther; 2013 Jan; 13(1):11-33. PubMed ID: 22992106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine.
    Safari D; Marradi M; Chiodo F; Th Dekker HA; Shan Y; Adamo R; Oscarson S; Rijkers GT; Lahmann M; Kamerling JP; Penadés S; Snippe H
    Nanomedicine (Lond); 2012 May; 7(5):651-62. PubMed ID: 22630149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.